Shanghai, China, May22,2024 – Shanghai Henlius Biotech, Inc. (2696.HK) announced that the supplementalnew drug applications of its independently developed adalimumab biosimilarHANDAYUAN for the four new indications of polyarticular juvenile idiopathicarthritis, pediatric plaque psoriasis, Crohn’s disease and pediatric Crohn’sdisease have been approved by t

On 14 May, Fosun Health and Foshan Chancheng District Chanxi New City Investment and Construction Co., Ltd. (hereinafter referred to as "Foshan Chanxi City Investment") entered into a "Capital Increase and Share Expansion Agreement". According to the agreement, Foshan Chanxi City Investment proposed to designate entities (including funds,

On 15 May, a massive scroll unfurled in the central square of Yuyuan Garden in Shanghai. Close to a hundred families collectively painted the "Fosun lifestyle" scroll, illuminating the "star of Fosun". At the same time, thousands of families painted the "Fosun lifestyle" scroll in 20 commercial districts and communities such as Shanghe Yinxiang in Ru

On 13 May 2024, Fortune China magazine released the 2024 China ESG Impact List, and Fosun International Limited (“Fosun International”or the “Company”) (HKEX stock code: 00656) was included in the list, highlighting its outstanding performance and industry leadership in the areas of environmental, social and governance (ESG).FortuneChinapointed out

On May 14th, Guo Guangchang, Chairman of Fosun International, along with a delegation, paid a visit to the Chinese Embassy in Paris, where they met with the Chinese Ambassador to France, Lu Shaye. Economic and Commercial Minister Counselor Shen Xiang from the embassy was also in attendance.Guo Guangchang introduces Fosun’s operation in France in meet

Visiting international organizations, experiencing a variety of exciting workshops, touring museums and art galleries, city walks through the streets of New York, and interesting soul collisions...The 2024 Emerging Visionaries Awards “Charity Ambassadors” Zheyi Yeand Ko Cheng-ruei, have successfully completed their trip to the USA. What do they have to s

Shanghai, China, May 6, 2024-Shanghai Henlius Biotech, Inc. (2696.HK) announced that the investigational new drug application (IND) for phase 3 international multicenter clinical study of Henlius’ novel anti-HER2 mAb, HLX22, in combination with trastuzumab and chemotherapy for the first-line treatment of HER2-positive advanced gastric cancer has been approve

·HLX02 (trastuzumab-strf, trade name: HANQUYOU in China, HERCESSI™ in the U.S. and Zercepac^®in Europe) is a China-developed mAb biosimilar approved in China, Europe, and U.S.·HLX02 was approved in more than 40 countries and regions around the world, benefiting more than 180,000 patients·Henlius accelerates global expansion, delivering

(Hong Kong, 26 April 2024) Fosun International Limited (HKEX stock code: 00656, “Fosun International”), together with its subsidiaries (“Fosun” or the “Group”), today issued the Environmental, Social and Governance (ESG) Report 2023 (the “ESG Report”).Facing the increasingly severe challenges of global climate change, Fosun released its second